[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)]
[Pages 32703-32704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14912]



Centers for Disease Control and Prevention

[30 Day-17-17NE]

Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Survey of Engineered Nanomaterial Occupational Safety and Health 
Practices--New--National Institute for Occupational Safety and Health 
(NIOSH), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    As mandated in the Occupational Safety and Health Act of 1970 (PL 
91-596), NIOSH's mission is to conduct research and investigations on 
work-related disease and injury and to disseminate information for 
preventing identified workplace hazards (Sections 20 (a)(1) and (d)). 
This dual responsibility recognizes the need to translate research into 
workplace application if it is to impact worker safety and well-being. 
The goal of this project is to assess the relevance and impact of 
NIOSH's contribution to guidelines and risk mitigation practices for 
safe handling of engineered nanomaterials in the workplace. The 
intended use of this data is to inform NIOSH's research agenda to 
enhance its relevance and impact on worker safety and health in the 
context of engineered nanomaterials.
    The research under this project will survey companies who 
manufacture, distribute, fabricate, formulate, use or provide services 
related to engineered nanomaterials. The analysis will describe the 
survey sample, response rates, and types of company by industry and 
size. Further analysis will focus on identifying the types of 
engineered nanomaterials being used in industry and the types of 
occupational safety and health practices being implemented. The 
analysis will be used to develop a final report which evaluates the 
influence of NIOSH products, services, and outputs on industry 
occupational safety and health practices.
    Under this project, the following activities and data collections 
will be conducted:
    (1) Company Pre-calls. Sampled companies will be contacted to 
identify the person who will complete the survey and to ascertain 
whether or not the company handles engineered nanomaterials.
    (2) Survey. A web-based questionnaire, with a mail option, will be 
administered to companies. The purpose of the survey is to learn 
directly from companies about their use of NIOSH materials and their 
occupational safety and health practices concerning engineered 
    A sample of 600 companies will be compiled from lists of industry 
associations, research reports, marketing databases, and web-based 
searches. Of the 600 selected companies we anticipate that 500 will 
complete the survey within two years. The company pre-call is expected 
to require five minutes to complete. The survey is expected to require 
20 minutes to complete; including the time it may take respondents to 
look-up and retrieve needed information. The estimated annualized 
burden hours for the respondents' time to participate in this 
information collection is 109 hours.

[[Page 32704]]

There are no costs to the responders other than their time.

                                        Estimated Annualized Burden Hours
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response (in
                                                                                    respondent        hours)
Receptionist..........................  Pre-call................             300               1            5/60
Occupational health and safety          Survey..................             100               1           20/60
Industrial Production Managers........  Survey..................              75               1           20/60
Natural Sciences Managers.............  Survey..................              75               1           20/60

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-14912 Filed 7-14-17; 8:45 am]